(3) EN: Trials demonstrated modest but meaningful benefits when combined with the potentiator ivacaftor: ~3–4% improvement in lung function and ~30–35% reduction in exacerbations. 👨🏻‍🔬🧬🫁💊

#CysticFibrosis #PrecisionMedicine #Lumacaftor #Tezacaftor #PrIMR